Research Rochester’s Pinpoint Gene Control Boosts Parkinson’s Research By URMC Communications Aug. 23, 2010 A technology developed at the University of Rochester Medical Center that enables scientists to turn on genes exactly when and where they want in the nervous system is helping scientists in the hunt ...
Research Scientists Pinpoint Earliest Steps of Common Form of Muscular Dystrophy By URMC Communications Aug. 19, 2010 Nearly two decades after they identified the specific genetic flaw that causes a common type of muscular dystrophy, scientists believe they have figured out how that flaw brings about the disease. ...
Research Acupuncture’s Molecular Effects Pinned Down By URMC Communications May. 30, 2010 In a paper published online May 30 in Nature Neuroscience, a team at the University of Rochester Medical Center identifies the molecule adenosine as a central player in parlaying some of the effects ...
Patient Care URMC’s First Chief of Child Neurology Dies By URMC Communications May. 24, 2010 Frederick A. Horner, M.D., the first chief of Child Neurology at the University of Rochester School of Medicine and Dentistry, died April 20, 2010, at the age of 90.
Patient Care Variations in Decisions for Care of Patients with Brain Injury “Disturbing” By Mark Michaud May. 12, 2010 Treatment decisions involving patients with severe brain injury vary widely between medical institutions, and appear to be more driven by hospital and physician practices and priorities. In an ...
Research URMC Named Batten Disease Center of Excellence By URMC Communications May. 11, 2010 The Batten Disease Support and Research Association named the University of Rochester Medical Center (URMC) a Batten Disease Center of Excellence today because of its comprehensive services for ...
Research Heart Drug Effective for Treating Symptom of Muscular Dystrophy By URMC Communications May. 3, 2010 A medication most often used to treat heart arrhythmias also reduces a central symptom of myotonic dystrophy, the most common type of muscular dystrophy in adults. The findings about the medication ...
Research URMC Receives $4.5 Million in NYS Stem Cell Grants By Mark Michaud Mar. 25, 2010 The University of Rochester Medical Center has received a total of $4.5 million in funding from the Empire State Stem Cell Board for research in neurological disease, cancer, cardiovascular disease, ...
Research New Center to Focus on Early Stage Clinical Research By Mark Michaud Mar. 2, 2010 A new initiative at the University of Rochester Medical Center will provide academic and industry researchers the expertise and scientific collaboration necessary to conduct early stage clinical ...
Research Drug Shows Promise for Huntington’s Disease By Mark Michaud Feb. 8, 2010 An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington’s disease appears to be safe and may improve cognition. That is the conclusion of a study ...
